Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Irizar, Haritz ^a,b   Muñoz Culla, Maider ^a,b   Sepú Lveda, Lucia ^a   Sáenz Cuesta, Matias ^a,b   Prada, Alvaro ^b,c   Castillo Triviño, Tamara ^a,b   Zamora Ló Pez, Gorka ^d,e   De Munain, Adolfo Lopez ^c,f   Olascoaga, Javier ^a,b,c   Otaegui, David ^a,b  

^a BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^b REEM: Spanish Network on Multiple Sclerosis   (Spain)

^c HOSPITAL DONOSTIA   (Spain)

^d HUMBOLDT UNIVERSITY   (Germany)

^e UNIVERSITAT POMPEU FABRA   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; TCN1 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; TRANSCOBALAMIN; TRANSCRIPTOME;

ADULT; ARTICLE; B LYMPHOCYTE; BZLF1 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EBNA1 GENE; EBNA2 GENE; EPSTEIN BARR VIRUS; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; LMP1 GENE; LMP2 GENE; MALE; MOLECULAR MECHANICS; MULTIPLE SCLEROSIS; NEUTROPHIL; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RELAPSE; REMISSION; SEX DIFFERENCE; SEX ROLE; UPREGULATION; VIRUS GENE; VIRUS REACTIVATION; AGED; BIOLOGICAL MODEL; BLOOD; DNA MICROARRAY; EPSTEIN BARR VIRUS INFECTION; GENE REGULATORY NETWORK; GENETICS; LEUKOCYTE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS ACTIVATION; YOUNG ADULT;

ADULT; AGED; B-LYMPHOCYTES; DISEASE PROGRESSION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE REGULATORY NETWORKS; HERPESVIRUS 4, HUMAN; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MODELS, GENETIC; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX FACTORS; TRANSCOBALAMINS; TRANSCRIPTOME; VIRUS ACTIVATION; YOUNG ADULT;

EID: 84896503846     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090482     Document Type: Article

References (46)

1. Baranzini SE, Nickles D (2012) Genetics of multiple sclerosis: swimming in an ocean of data. Curr Opin Neurol 25: 239-245. 10.1097/WCO.0- b013e3283533a93 [doi].
2. van der Mei IA, Simpson S Jr, Stankovich J, Taylor BV (2011) Individual and joint action of environmental factors and risk of MS. Neurol Clin 29: 233-255. S0733-8619(10)00160-X [pii];10.1016/j.ncl.2010.12.007 [doi].
3. Bennett JL, Stuve O (2009) Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implications. Clin Neuropharmacol 32: 121-132. 10.1097/WNF.0b013e3181880359 [doi];00002826- 200905000-00001 [pii].
4. Disanto G, Morahan JM, Barnett MH, Giovannoni G, Ramagopalan SV (2012) The evidence for a role of B cells in multiple sclerosis. Neurology 78: 823-832. 78/11/823 [pii];10.1212/WNL.0b013e318249f6f0 [doi].
5. Liu L, Belkadi A, Darnall L, Hu T, Drescher C, et al. (2010) CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis. Nat Neurosci 13: 319-326. nn.2491 [pii];10.1038/nn.2491 [doi].
6. Sayed BA, Christy AL, Walker ME, Brown MA (2010) Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment? J Immunol 184: 6891- 6900. jimmunol.1000126 [pii];10.4049/jimmunol.1000126 [doi].
7. Elenein RG, Sharer LR, Cook SD, Pachner AR, Michaels J, et al. (2011) A second case of Marburg's variant of multiple sclerosis with vasculitis and extensive demyelination. Mult Scler 17: 1531-1538. 1352458511414042 [pii];10.1177/1352458511414042 [doi].
8. Herges K, de Jong BA, Kolkowitz I, Dunn C, Mandelbaum G, et al. (2012) Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein. Mult Scler 18: 398- 408. 1352458512440060 [pii];10.1177/1352458512440060 [doi].
9. Saadoun S, Waters P, MacDonald C, Bell BA, Vincent A, et al. (2012) Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin Ginduced damage in mouse brain. Ann Neurol 71: 323-333. 10.1002/ana.22686 [doi].
10. Naegele M, Tillack K, Reinhardt S, Schippling S, Martin R, et al. (2012) Neutrophils in multiple sclerosis are characterized by a primed phenotype. J Neuroimmunol 242: 60-71. S0165-5728(11)00332-8 [pii];10.1016/j.jneuroim. 2011.11.009 [doi].
11. Dieci G, Fiorino G, Castelnuovo M, Teichmann M, Pagano A (2007) The expanding RNA polymerase III transcriptome. Trends Genet 23: 614-622. S0168-9525(07)00307-1 [pii];10.1016/j.tig.2007.09.001 [doi]. (Pubitemid 350180140)
12. Dieci G, Preti M, Montanini B (2009) Eukaryotic snoRNAs: a paradigm for gene expression flexibility. Genomics 94: 83-88. S0888-7543(09)00106-2 [pii];10.1016/j.ygeno.2009.05.002 [doi].
13. Felton-Edkins ZA, Kondrashov A, Karali D, Fairley JA, Dawson CW, et al. (2006) Epstein-Barr virus induces cellular transcription factors to allow active expression of EBER genes by RNA polymerase III. J Biol Chem 281: 33871- 33880. M600468200 [pii];10.1074/jbc.M600468200 [doi]. (Pubitemid 46036599)
14. Mrazek J, Kreutmayer SB, Grasser FA, Polacek N, Huttenhofer A (2007) Subtractive hybridization identifies novel differentially expressed ncRNA species in EBV-infected human B cells. Nucleic Acids Res 35: e73. gkm244 [pii];10.1093/nar/gkm244 [doi]. (Pubitemid 47073615)
15. Plessy C, Pascarella G, Bertin N, Akalin A, Carrieri C, et al. (2012) Promoter architecture of mouse olfactory receptor genes. Genome Res 22: 486-497. gr.126201.111 [pii];10.1101/gr.126201.111 [doi].
16. Wang MM, Tsai RY, Schrader KA, Reed RR (1993) Genes encoding components of the olfactory signal transduction cascade contain a DNA binding site that may direct neuronal expression. Mol Cell Biol 13: 5805-5813. (Pubitemid 23260681)
17. Milatovich A, Qiu RG, Grosschedl R, Francke U (1994) Gene for a tissuespecific transcriptional activator (EBF or Olf-1), expressed in early B lymphocytes, adipocytes, and olfactory neurons, is located on human chromosome 5, band q34, and proximal mouse chromosome 11. Mamm Genome 5: 211-215. (Pubitemid 2082222)
18. Wang SS, Tsai RY, Reed RR (1997) The characterization of the Olf-1/EBF-like HLH transcription factor family: implications in olfactory gene regulation and neuronal development. J Neurosci 17: 4149-4158. (Pubitemid 27220606)
19. Zhao B, Zou J, Wang H, Johannsen E, Peng CW, et al. (2011) Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc Natl Acad Sci U S A 108: 14902-14907. 1108892108 [pii];10.1073/pnas.1108892108 [doi].
20. Davies ML, Xu S, Lyons-Weiler J, Rosendorff A, Webber SA, et al. (2010) Cellular factors associated with latency and spontaneous Epstein-Barr virus reactivation in B-lymphoblastoid cell lines. Virology 400: 53-67. S0042- 6822(10)00012-7 [pii];10.1016/j.virol.2010.01.002 [doi].
21. Klein SL (2012) Immune cells have sex and so should journal articles. Endocrinology 153: 2544-2550. en.2011-2120 [pii];10.1210/en.2011-2120 [doi].
22. Correale J, Ysrraelit MC, Gaitan MI (2010) Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. J Immunol 185: 4948-4958. jimmunol.1000588 [pii];10.4049/jimmunol.1000588 [doi].
23. Ramagopalan SV, Byrnes JK, Orton SM, Dyment DA, Guimond C, et al. (2010) Sex ratio of multiple sclerosis and clinical phenotype. Eur J Neurol 17: 634-637. ENE2850 [pii];10.1111/j.1468-1331.2009.02850.x [doi].
24. Eikelenboom MJ, Killestein J, Kragt JJ, Uitdehaag BM, Polman CH (2009) Gender differences in multiple sclerosis: cytokines and vitamin D. J Neurol Sci 286: 40-42. S0022-510X(09)00664-9 [pii];10.1016/j.jns.2009.06.025 [doi].
25. Irizar H, Munoz-Culla M, Zuriarran O, Goyenechea E, Castillo-Trivino T, et al. (2011) HLA-DRB1*15:01 and multiple sclerosis: a female association? Mult Scler. 1352458511426813 [pii];10.1177/1352458511426813 [doi].
26. Camina-Tato M, Morcillo-Suarez C, Bustamante MF, Ortega I, Navarro A, et al. (2010) Gender-associated differences of perforin polymorphisms in the susceptibility to multiple sclerosis. J Immunol 185: 5392-5404. jimmunol. 1000102 [pii];10.4049/jimmunol.1000102 [doi].
27. Achiron A, Gurevich M (2009) Gender effects in relapsing-remitting multiple sclerosis: correlation between clinical variables and gene expression molecular pathways. J Neurol Sci 286: 47-53. S0022-510X(09)00694-7 [pii];10.1016/ j.jns.2009.06.038 [doi].
28. Menon R, Di DM, Cordiglieri C, Musio S, La ML, et al. (2012) Gender-based blood transcriptomes and interactomes in multiple sclerosis: involvement of SP1 dependent gene transcription. J Autoimmun 38: J144-J155. S0896- 8411(11)00117-X [pii];10.1016/j.jaut.2011.11.004 [doi].
29. De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, et al. (2008) Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology 70: 1113-1118. 01.wnl.0000294325.63006.f8 [pii];10.1212/01.wnl.0000294325.63006.f8 [doi]. (Pubitemid 351464768)
30. Sundstrom P, Nystrom M, Ruuth K, Lundgren E (2009) Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis. J Neuroimmunol 215: 102-107. S0165-5728(09)00309-9 [pii];10.1016/j.jneuroim.2009.08.004 [doi].
31. Sundqvist E, Sundstrom P, Linden M, Hedstrom AK, Aloisi F, et al. (2012) Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immun 13: 14-20. gene201142 [pii];10.1038/gene.2011.42 [doi].
32. Irizar H, Munoz-Culla M, Zuriarrain O, Goyenechea E, Castillo-Trivino T, et al. (2012) HLA-DRB1*15:01 and multiple sclerosis: a female association? Mult Scler 18: 569-577. 1352458511426813 [pii];10.1177/1352458511426813 [doi].
33. Hazra A, Kraft P, Lazarus R, Chen C, Chanock SJ, et al. (2009) Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. Hum Mol Genet 18: 4677-4687. ddp428 [pii];10.1093/hmg/ddp428 [doi].
34. Lin X, Lu D, Gao Y, Tao S, Yang X, et al. (2012) Genome-wide association study identifies novel loci associated with serum level of vitamin B12 in Chinese men. Hum Mol Genet 21: 2610-2617. dds062 [pii];10.1093/hmg/dds062 [doi].
35. Miller A, Korem M, Almog R, Galboiz Y (2005) Vitamin B12, demyelination, remyelination and repair in multiple sclerosis. J Neurol Sci 233: 93-97. S0022- 510X(05)00087-0 [pii];10.1016/j.jns.2005.03.009 [doi]. (Pubitemid 40804822)
36. van Rensburg SJ, Kotze MJ, Hon D, Haug P, Kuyler J, et al. (2006) Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis. Metab Brain Dis 21: 121-137. 10.1007/s11011-006-9019-0 [doi].
37. Mastronardi FG, Min W, Wang H, Winer S, Dosch M, et al. (2004) Attenuation of experimental autoimmune encephalomyelitis and nonimmune demyelination by IFN-beta plus vitamin B12: treatment to modify notch-1/sonic hedgehog balance. J Immunol 172: 6418-6426. (Pubitemid 38621251)
38. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121- 127.
39. Castillo-Trivino T, Mowry EM, Gajofatto A, Chabas D, Crabtree-Hartman E, et al. (2011) Switching multiple sclerosis patients with breakthrough disease to second-line therapy. PLoS ONE 6: e16664. 10.1371/journal.pone.0016664 [doi].
40. Saeed AI, Sharov V, White J, Li J, Liang W, et al. (2003) TM4: a free, opensource system for microarray data management and analysis. Biotechniques 34: 374-378. (Pubitemid 36184095)
41. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, et al. (2006) TM4 microarray software suite. Methods Enzymol 411: 134-193. S0076- 6879(06)11009-5 [pii];10.1016/S0076-6879(06)11009-5 [doi]. (Pubitemid 44291425)
42. Greer JM, McCombe PA (2011) Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms. J Neuroimmunol 234: 7-18. S0165- 5728(11)00065-8 [pii];10.1016/j.jneuroim.2011.03.003 [doi].
43. Baranzini SE, Mousavi P, Rio J, Caillier SJ, Stillman A, et al. (2005) Transcription-based prediction of response to IFNbeta using supervised computational methods. PLoS Biol 3: e2.
44. Hong F, Breitling R, McEntee CW, Wittner BS, Nemhauser JL, et al. (2006) RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 22: 2825-2827. btl476 [pii];10.1093/ bioinformatics/ btl476 [doi]. (Pubitemid 44742407)
45. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498-2504. 10.1101/gr.1239303 [doi];13/11/ 2498 [pii]. (Pubitemid 37428274)
46. Kubota N, Wada K, Ito Y, Shimoyama Y, Nakamura S, et al. (2008) One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection. J Virol Methods 147: 26-36. S0166-0934(07)00298-4 [pii];10.1016/j.jviromet.2007.08.012 [doi]. (Pubitemid 350250845)